Clinical trial
Chemotherapy in Treating Patients With Recurrent Malignant Glioma
NCT00002986 · Duke University, Other · Completed
Key facts
| NCT number | NCT00002986 |
|---|---|
| Title | Chemotherapy in Treating Patients With Recurrent Malignant Glioma |
| Official title | Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962) |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | carmustine, topotecan hydrochloride |
| Enrollment | 36 |
| Start date | Feb 1, 1997 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: